Cited by 128Treatment of Major DepressionNeurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

Ketamine inhibits monoamine transporters expressed in human embryonic kidney 293 cells

Open access
Nishimura, Mitsuhiro, Sato, Kohji, Okada, Tomoya, Yoshiya, Ikuto, Schloss, Patrick, Shimada, Shoichi, Tohyama, Masaya·1998·Anesthesiology

Abstract

Background: Ketamine has been characterized as having psychotomimetic and sympathomimetic effects. These symptoms have raised the possibility that ketamine affects monoaminergic neurotransmission. To elucidate the relation between ketamine and monoamine transporters, the authors constructed three cell lines that stably express the norepinephrine, dopamine, and serotonin transporters and investigated the effects of ketamine on these transporters. Methods: Human embryonic kidney cells were transfected using the Chen-Okayama method with the human norepinephrine, rat dopamine, and rat serotonin transporter cDNA subcloned into the eukaryotic expression vector. Using cells stably expressing these transporters, the authors investigated the effects of ketamine on the uptake of these compounds and compared them with those of pentobarbital. Results: Inhibition analysis showed that ketamine significantly inhibited the uptake of all three monoamine transporters in a dose-dependent manner. The Ki (inhibition constant) values of ketamine on the norepinephrine, dopamine, and serotonin transporters were 66.8 microM, 62.9 microM, and 162 microM, respectively. Pentobarbital, a typical general anesthetic agent with no psychotic symptoms, did not affect the uptake of monoamines, however. Further, neither the glycine transporter 1 nor the glutamate/aspartate transporter was affected by ketamine, indicating that ketamine preferentially inhibits monoamine transporters. Conclusions: Ketamine inhibited monoamine transporters expressed in human embryonic kidney cells in a dose-dependent manner. This result suggests that the ketamine-induced inhibition of monoamine transporters might contribute to its psychotomimetic and sympathomimetic effects through potentiating monoaminergic neurotransmission.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00000542-199803000-00029

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • At high concentrations, ketamine inhibited NET, DAT, and SERT with Ki values of 66.8, 62.9, and 162 μM, respectively.

    “it was found that high concentrations of ketamine (Ki = 66.8, 62.9, and 162 μM) can functionally inhibit NET, DAT, and SERT respectively (Nishimura et al., 1998).”

    From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Nishimura et al., 1998

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [4]4. plex in mice. Brain Res 1992; 596:1-9
  2. [9]9. pamine neurons in the nucleus accumbens of mice. Pharmacol Biochem Beh 1991; 40:399-407
  3. [19]19. Akunne HC, Reid AA, Thurkauf A, Jacobson AE, De Costa BR, Rice KC, Heyes MP, Rothman RB: [3H] 1-[2-(2-Thienyl)cyclohexyl]peperidine labels two high-affinity binding sites in human cortex: Further evidence for phencyclidine binding sites associated with the biogenic amine reuptake complex. Synapse 1991; 8:289–300

Cited by

Sorted by citations

Authors
Nishimura, M., Sato, K., Okada, T., Yoshiya, I., Schloss, P., Shimada, S., & Tohyama, M.
Affiliations
  • Osaka University Hospital (JP)
  • The University of Osaka (JP)
  • Max Planck Society (DE)
Venue
Anesthesiology
Published
1998-03-01
Volume
88
Issue
3
Pages
768-774
ISSN
0003-3022 (ISSN-L)
OpenAlex
W2091155334
Cited by
128
References
20
Citations by year
2026: 5 · 2025: 7 · 2024: 5 · 2023: 5 · 2022: 4 · 2021: 11 · 2020: 10 · 2019: 11 · 2018: 5 · 2017: 11 · 2016: 11 · 2015: 3 · 2014: 3 · 2013: 5 · 2012: 4
FWCI
1.30
Type
journal article
Language
en
Open access
Locations
  • Anesthesiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
ketamine, monoamine transporters, norepinephrine transporter, dopamine transporter, serotonin transporter, psychotomimetic effects, sympathomimetic effects, monoaminergic neurotransmission, transporter inhibition, pentobarbital, glycine transporter 1, GLAST, general anesthetics
MeSH terms
Anesthetics, Dissociative, Animals, Biological Transport, Carrier Proteins, Cell Line, Humans, Ketamine, Membrane Glycoproteins, Nerve Tissue Proteins, Recombinant Proteins, ATP-Binding Cassette Transporters, Membrane Transport Proteins, Amino Acid Transport Systems, Neutral, Amino Acid Transport System X-AG, Symporters, Dopamine Plasma Membrane Transport Proteins, Norepinephrine Plasma Membrane Transport Proteins, Serotonin Plasma Membrane Transport Proteins, Glycine Plasma Membrane Transport Proteins, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review